HIV Prevention
Dates
09/30/2016 - 09/30/2019
Authors
Carlos Malvestutto, MD, MPH
Objective(s)
As a result of this educational activity, webcast participants will be able to: DEFINE PrEP in the context of the current AIDS Epidemic; REVIEW the scientific evidence supporting PrEP use; SHARE data on the awareness and uptake of PrEP in high risk populations; DISCUSS Guidelines for PrEP Implementation; and DISCUSS future PrEP modalities.
Description
Today on MedNet21, we're going to discuss HIV Prevention. The program will discuss the prevalence of HIV infection in different demographics in order to allow viewers to better screen patients for HIV risk factors. Studies demonstrating the effectiveness of tenofovir/emtricitabine in different patient populations will be presented. Recommendations for the use of pre-exposure prophylaxis as well as common side effects will be discussed.
Price(s)
Type |
Price |
Standard Price
|
$25.00
|
OSU Affiliated Faculty/Staff
|
$0.00
|
MedNet 21 Hospital Subscribers
|
$0.00
|
Accreditation Statement
The Ohio State University Center for Continuing Medical Education (CCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
Downloadable Files
to view PDFs download
Adobe Reader
Name |
|
Disclosure Information for Planning Committee Members and Speakers
|
|
Listen to Audio Only CME Podcasts
http://u.osu.edu/mednet21/2014/12/01/listen-to-audio-only-cme-podcasts/
|
|
HIV Prevention - 2
|
|
HIV Prevention - 4
|
|
HIV Prevention - 2 - in color
|
|
HIV Prevention - 4 - in color
|
|